相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Galectin-3 Performance in Histologic and Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis
Pierpaolo Trimboli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy
Riyao Yang et al.
SCIENCE CHINA-LIFE SCIENCES (2017)
Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma
Yidong Liu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
Lucas Daniel Gentilini et al.
ONCOTARGET (2017)
Combined Anti-VEGF and Anti-CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
Xinqi Wu et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
S. A. Harrison et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Inhibition of Galectin-1 Sensitizes HRAS-driven Tumor Growth to Rapamycin Treatment
James V. Michael et al.
ANTICANCER RESEARCH (2016)
Roles of Galectin-7 in Cancer
Manpreet Kaur et al.
Asian Pacific Journal of Cancer Prevention (2016)
Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells
Marisa M. Fernandez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Galectin 3 as a guardian of the tumor microenvironment
Peter P. Ruvolo
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells
Peter P. Ruvolo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Galectin-12 inhibits granulocytic differentiation of human NB4 promyelocytic leukemia cells while promoting lipogenesis
Huiting Xue et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Recombinant expression, purification and preliminary biophysical and structural studies of C-terminal carbohydrate recognition domain from human galectin-4
Joane K. Rustiguel et al.
PROTEIN EXPRESSION AND PURIFICATION (2016)
Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer
Fang Peng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer
Meenakshi Upreti et al.
ONCOTARGET (2016)
Structural characterisation of human galectin-4 N-terminal carbohydrate recognition domain in complex with glycerol, lactose, 3′-sulfo-lactose, and 2′-fucosyllactose
Khuchtumur Bum-Erdene et al.
SCIENTIFIC REPORTS (2016)
Crystallization of Galectin-8 Linker Reveals Intricate Relationship between the N-terminal Tail and the Linker
Yunlong Si et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Polymeric Nanomedicine for Tumor-Targeted Combination Therapy to Elicit Synergistic Genotoxicity against Prostate Cancer
Qingqing Yang et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux
Valerie R. Wiersma et al.
AUTOPHAGY (2015)
Galectin expression in cancer diagnosis and prognosis: A systematic review
Victor L. Thijssen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
NMR assignments of the C-terminal domain of human galectin-8
Chun-Hao Gerard Liu et al.
BIOMOLECULAR NMR ASSIGNMENTS (2015)
Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[18F]fluoroethylazide, and in vivo evaluation
Tilman Lappchen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Galectin-3 in autoimmunity and autoimmune diseases
Felipe L. de Oliveira et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Structural characterization of human galectin-4 C-terminal domain: elucidating the molecular basis for recognition of glycosphingolipids, sulfated saccharides and blood group antigens
Khuchtumur Bum-Erdene et al.
FEBS JOURNAL (2015)
Impact of Exogenous Galectin-9 on Human T Cells CONTRIBUTION OF THE T CELL RECEPTOR COMPLEX TO ANTIGEN-INDEPENDENT ACTIVATION BUT NOT TO APOPTOSIS INDUCTION
Claire Lhuillier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
G3-C12 Peptide Reverses Galectin-3 from Foe to Friend for Active Targeting Cancer Treatment
Wei Sun et al.
MOLECULAR PHARMACEUTICS (2015)
Pectin in cancer therapy: A review
Wenbo Zhang et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2015)
Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
Hangcheng Fu et al.
TUMOR BIOLOGY (2015)
Extracellular galectin-3 programs multidrug resistance through Na plus /K plus -ATPase and P-glycoprotein signaling
Yosuke Harazono et al.
ONCOTARGET (2015)
Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin
Maria Claudia Vladoiu et al.
ONCOTARGET (2015)
Changed Expression of E-cadherin and Galectin-9 in Oral Squamous Cell Carcinomas but Lack of Potential as Prognostic Markers
Siew Wui Chan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides
Hidenori Kawashima et al.
BJU INTERNATIONAL (2014)
Why anti-Bcl-2 clinical trials fail: a solution
Y. Harazono et al.
CANCER AND METASTASIS REVIEWS (2014)
A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor-Infiltrating Lymphocytes
Nathalie Demotte et al.
CLINICAL CANCER RESEARCH (2014)
OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis
Lucile Astorgues-Xerri et al.
EUROPEAN JOURNAL OF CANCER (2014)
Galectin-8: A matricellular lectin with key roles in angiogenesis
Maria F. Troncoso et al.
GLYCOBIOLOGY (2014)
Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack
Wei Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Targeting Prostate Carcinoma by G3-C12 Peptide Conjugated N-(2-Hydroxypropyl)methacrylamide Copolymers
Yang Yang et al.
MOLECULAR PHARMACEUTICS (2014)
Varied expression and localization of multiple galectins in different cancer cell lines
Arun Satelli et al.
ONCOLOGY REPORTS (2014)
Expression and functions of galectin-7 in ovarian cancer
Marilyne Labrie et al.
ONCOTARGET (2014)
Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis Glycans make the difference
Diego O. Croci et al.
ONCOIMMUNOLOGY (2014)
Synergistic Effects of PectaSol-C Modified Citrus Pectin an Inhibitor of Galectin-3 and Paclitaxel on Apoptosis of Human SKOV-3 Ovarian Cancer Cells
Ghamartaj Hossein et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib
Massimo Zucchetti et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
Tomas Dalotto-Moreno et al.
CANCER RESEARCH (2013)
A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
Diego J. Laderach et al.
CANCER RESEARCH (2013)
Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide
Jessica R. Newton-Northup et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Human Galectin-3 Selective and High Affinity Inhibitors. Present State and Future Perspectives
R. Tellez-Sanz et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Regulation of galectin-3-induced apoptosis of Jurkat cells by both O-glycans and N-glycans on CD45
Jing Xue et al.
FEBS LETTERS (2013)
Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix
Chiaojung Jillian Tsai et al.
GYNECOLOGIC ONCOLOGY (2013)
Roles of galectin-7 and S100A9 in cervical squamous carcinoma: Clinicopathological and in vitro evidence
Hong Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer
Ruud P. M. Dings et al.
INVESTIGATIONAL NEW DRUGS (2013)
Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
Tina Verschuere et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Understanding the Specificity of Human Galectin-8C Domain Interactions with Its Glycan Ligands Based on Molecular Dynamics Simulations
Sonu Kumar et al.
PLOS ONE (2013)
Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Peter G. Traber et al.
PLOS ONE (2013)
Galectin-4, a Novel Predictor for Lymph Node Metastasis in Lung Adenocarcinoma
Takuo Hayashi et al.
PLOS ONE (2013)
pH-Dependent Recycling of Galectin-3 at the Apical Membrane of Epithelial Cells
Tamara Straube et al.
TRAFFIC (2013)
Simultaneous determination of serum galectin-3 and-4 levels detects metastases in colorectal cancer patients
Hannah Barrow et al.
CELLULAR ONCOLOGY (2013)
Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer
Seung Won Kim et al.
CELLULAR ONCOLOGY (2013)
Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer
Seok-Jun Kim et al.
ONCOTARGET (2013)
Structure-Based Optimization of Angiostatic Agent 6DBF7, an Allosteric Antagonist of Galectin-1
Ruud P. M. Dings et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
Zhao-Yang Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates
Yang Yang et al.
BIOMATERIALS (2012)
Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma
Filiberto Cedeno-Laurent et al.
BLOOD (2012)
Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
Mary C. Clark et al.
BLOOD (2012)
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Koichi Ito et al.
CANCER AND METASTASIS REVIEWS (2012)
Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma
Ru Chen et al.
CANCER BIOLOGY & THERAPY (2012)
Combination effect of PectaSol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU-145 and LNCaP prostate cancer cell lines
Najmeh Tehranian et al.
CELL BIOLOGY INTERNATIONAL (2012)
Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence
Koichi Ito et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Association of galectin-3 expression with melanoma progression and prognosis
Ewan R. Brown et al.
EUROPEAN JOURNAL OF CANCER (2012)
Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor
Geoffrey Masuyer et al.
FEBS JOURNAL (2012)
High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer
Dong Tang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
Diego O. Croci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Metabolic Inhibition of Galectin-1-Binding Carbohydrates Accentuates Antitumor Immunity
Filiberto Cedeno-Laurent et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Antitumor Agent Calixarene 0118 Targets Human Galectin-1 as an Allosteric Inhibitor of Carbohydrate Binding
Ruud P. M. Dings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells
Veronica Veschi et al.
PLOS ONE (2012)
Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent
Ju Bo Wang et al.
PEPTIDES (2012)
Methodology and Technical Requirements of the Galectin-3 Test for the Preoperative Characterization of Thyroid Nodules
Armando Bartolazzi et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
Koichi Ito et al.
ANGIOGENESIS (2011)
Galectin-3-A jack-of-all-trades in cancer
Anna U. Newlaczyl et al.
CANCER LETTERS (2011)
Serum Galectin-2,-4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium
Hannah Barrow et al.
CLINICAL CANCER RESEARCH (2011)
Galectin-4 functions as a tumor suppressor of human colorectal cancer
Arun Satelli et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The Anti-angiogenic Peptide Anginex Greatly Enhances Galectin-1 Binding Affinity for Glycoproteins
Emma Salomonsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lung Cancer-Derived Galectin-1 Mediates Dendritic Cell Anergy through Inhibitor of DNA Binding 3/IL-10 Signaling Pathway
Po-Lin Kuo et al.
JOURNAL OF IMMUNOLOGY (2011)
Decreased Galectin-8 Is a Strong Marker for Recurrence in Urothelial Carcinoma of the Bladder
Mario Wolfgang Kramer et al.
UROLOGIA INTERNATIONALIS (2011)
Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells
Melanie Demers et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Inhibiting Tumor Growth by Targeting Tumor Vasculature with Galectin-1 Antagonist Anginex Conjugated to the Cytotoxic Acylfulvene, 6-Hydroxylpropylacylfulvene
Ruud P. M. Dings et al.
BIOCONJUGATE CHEMISTRY (2010)
GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
Matthew J. Streetly et al.
BLOOD (2010)
Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
Victor L. Thijssen et al.
CANCER RESEARCH (2010)
A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
Nathalie Demotte et al.
CANCER RESEARCH (2010)
Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells
Xu-Yun Zhao et al.
CARCINOGENESIS (2010)
MLL-Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1
Przemyslaw Juszczynski et al.
CLINICAL CANCER RESEARCH (2010)
Tumor suppressor p16INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model
Hugo Sanchez-Ruderisch et al.
FEBS JOURNAL (2010)
PectaSol-C Modified Citrus Pectin Induces Apoptosis and Inhibition of Proliferation in Human and Mouse Androgen-Dependent and -Independent Prostate Cancer Cells
Jun Yan et al.
INTEGRATIVE CANCER THERAPIES (2010)
Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia
Junya Kuroda et al.
MOLECULAR CANCER RESEARCH (2010)
Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness
Daniela Spano et al.
MOLECULAR MEDICINE (2010)
Galectin-9 trafficking regulates apical-basal polarity in Madin-Darby canine kidney epithelial cells
Rashmi Mishra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment
Y. Wang et al.
CELL DEATH & DISEASE (2010)
Anti-angiogenesis and anti-tumor effects of AdNT4-anginex
Dan Feng Dong et al.
CANCER LETTERS (2009)
Intracellular galectin-9 activates inflammatory cytokines in monocytes
Ai Matsuura et al.
GENES TO CELLS (2009)
The α-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain
Michelle C. Miller et al.
GLYCOBIOLOGY (2009)
Evaluation of galectin-8 expression in thyroid tumors
S. Savin et al.
MEDICAL ONCOLOGY (2009)
Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients
Pierre Vereecken et al.
MELANOMA RESEARCH (2009)
The galectin profile of the endothelium - Altered expression and localization in activated and tumor endothelial cells
Victor L. Thijssen et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Citrus pectin affects cytokine production by human peripheral blood mononuclear cells
Hertzel Salman et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven
Ruud P. M. Dings et al.
CANCER LETTERS (2008)
Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
Masako Seki et al.
CLINICAL IMMUNOLOGY (2008)
Dimeric galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain
Sean R. Stowell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
Keiko Nagahara et al.
JOURNAL OF IMMUNOLOGY (2008)
Galectin-3-expression analyses in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study
Armando Bartolazzi et al.
LANCET ONCOLOGY (2008)
Hypoxia and aggressive tumor phenotype: Implications for therapy and prognosis
Peter Vaupel
ONCOLOGIST (2008)
Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease
Sven Saussez et al.
THYROID (2008)
Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model
Veronique Mathieu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation
Lora Eshkar Sebban et al.
JOURNAL OF IMMUNOLOGY (2007)
Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma
Shigeki Katoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
The role of galectin-3 in cancer drug resistance
Tomoharu Fukumori et al.
DRUG RESISTANCE UPDATES (2007)
Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization
Ruud P. M. Dings et al.
CLINICAL CANCER RESEARCH (2007)
Anginex-conjugated liposomes for targeting of angiogenic endothelial cells
Ricardo J. M. G. E. Brandwijk et al.
BIOCONJUGATE CHEMISTRY (2007)
Galectin-7 in lymphoma:: Elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model
Melanie Demers et al.
CANCER RESEARCH (2007)
Involvement of integrins, MAPK, and NF-κB in regulation of the shear stress-induced MMP-9 expression in endothelial cells
Hui-Wen Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species
Yoshiyuki Matsui et al.
CANCER RESEARCH (2007)
Necrotic tumor cell death in vivo impairs tumor-specific immune responses
Jaba Gamrekelashvili et al.
JOURNAL OF IMMUNOLOGY (2007)
Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay
Morikazu Amano et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2007)
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
Victor L. J. L. Thijssen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Proteomic identification of new biomarkers and application in thyroid cytology
Carlos Torres-Cabala et al.
ACTA CYTOLOGICA (2006)
Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities
Ruud P. M. Dings et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer
T Fukumori et al.
CANCER RESEARCH (2006)
Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death
BN Stillman et al.
JOURNAL OF IMMUNOLOGY (2006)
High serum galectin-3 in advanced melanoma: preliminary results
P Vereecken et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes
K Ohtsubo et al.
CELL (2005)
Galectin-1: A link between tumor hypoxia and tumor immune privilege
QT Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells
D Chauhan et al.
CANCER RESEARCH (2005)
Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells
R Shalom-Feuerstein et al.
CANCER RESEARCH (2005)
Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein
RJMGE Brandwijk et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells
RPM Dings et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer
A Irie et al.
CLINICAL CANCER RESEARCH (2005)
Suppression of tumor growth by galectin-7 gene transfer
S Ueda et al.
CANCER RESEARCH (2004)
Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity
G Elad-Sfadia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity
KH Mayo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway
Y Kashio et al.
JOURNAL OF IMMUNOLOGY (2003)
Upregulation of galectins-1 and-3 in human colon cancer and their role in regulating cell migration
A Hittelet et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Galectin-4 in normal tissues and cancer
ME Huflejt et al.
GLYCOCONJUGATE JOURNAL (2003)
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin
P Nangia-Makker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors:: Diagnostic and biological implications
S Rorive et al.
MODERN PATHOLOGY (2002)
Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells
HM Lin et al.
ONCOGENE (2002)
Oligosaccharide specificity of galectins: a search by frontal affinity chromatography
J Hirabayashi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance
T Kageshita et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas
B Terris et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Association of galectin-9 with eosinophil apoptosis
N Saita et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity
M Sato et al.
GLYCOBIOLOGY (2002)
Introduction to galectins
H Leffler et al.
GLYCOCONJUGATE JOURNAL (2002)
Human galectin-8 isoforms and cancer
N Bidon-Wagner et al.
GLYCOCONJUGATE JOURNAL (2002)
Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation
A Paz et al.
ONCOGENE (2001)
Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures
H Lahm et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions
A Bartolazzi et al.
LANCET (2001)
Galectin-3 induces endothetial cell morphogenesis and angiogenesis
P Nangia-Makker et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
